Evidence map›Paper›PMID 38399460›Full record

ArticlePharmaceuticals (Basel, Switzerland)2024

Cutaneous Alternariosis in Immunosuppressed Patients Treated with Photodynamic Therapy and Oral Antifungals, a Synergistic Strategy.

Pedro Gil-Pallares, Tamara Gracia-Cazaña, Marcial Álvarez-Salafranca, Marcos Antonio Gorgojo, Mar García-García, Antonio Beltrán-Rosel, Manuel Almenara-Blasco, Alba Navarro-Bielsa, Yolanda Gilaberte

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Pedro Gil-PallaresDepartment of Dermatology, Miguel Servet University Hospital, 50009 Zaragoza, Spain.
Tamara Gracia-CazañaDepartment of Dermatology, Miguel Servet University Hospital, 50009 Zaragoza, Spain.ORCID 0000-0002-0523-2076
Marcial Álvarez-SalafrancaDepartment of Dermatology, Miguel Servet University Hospital, 50009 Zaragoza, Spain.ORCID 0000-0002-1691-3280
Marcos Antonio GorgojoDepartment of Dermatology, San Jorge Hospital, 22004 Huesca, Spain.
Mar García-GarcíaDepartment of Pathology, Hospital Clínico Universitario Lozano Blesa, 50009 Zaragoza, Spain.
Antonio Beltrán-RoselDepartment of Microbiology, Hospital Clínico Universitario Lozano Blesa, 50009 Zaragoza, Spain.
Manuel Almenara-BlascoDepartment of Dermatology, Miguel Servet University Hospital, 50009 Zaragoza, Spain.
Alba Navarro-BielsaDepartment of Dermatology, Miguel Servet University Hospital, 50009 Zaragoza, Spain.ORCID 0000-0003-1171-6007
Yolanda GilaberteDepartment of Dermatology, Miguel Servet University Hospital, 50009 Zaragoza, Spain.ORCID 0000-0001-8034-3617
Hospital Universitario Miguel Servet · ESHospital Clínico Universitario Lozano Blesa · ESHospital General San Jorge · ESUniversidad de Zaragoza · ESUniversidade de Santiago de Compostela · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cutaneous alternariosis is a rare condition, more frequently presented in immunocompromised patients, which usually requires long courses of systemic antifungals that may interact with other medications. The presented series shows three cases of cutaneous alternariosis in immunocompromised patients and organ transplant recipients that were successfully treated with photodynamic therapy and oral antifungals, allowing a reduction in the systemic treatment duration and therefore decreasing the risk of side effects and drug interactions.

Indexed as

5-aminolevulinic acidAlternariacutaneous alternariosismethyl-aminolevulinatemethylene bluePDTphotodynamic therapy

Identifiers

PMID38399460
PMCPMC10893038
OpenAlexW4391821339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.